Bertozzi S, Londero AP, Cedolini C, Uzzau A, Seriau L, Bernardi S, et al. Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. Springerplus. 2015;4(1):688. https://doi.org/10.1186/s40064-015-1449-x.
Article
PubMed
PubMed Central
Google Scholar
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210.
Article
CAS
PubMed
Google Scholar
Bertozzi S, Londero AP, Bernardi S, Cedolini C. Applicability of the Notthingham prognostic index for predicting the survival of triple-negative invasive breast cancer in a single Italian center. Eur J Gynaecol Oncol. 2019;40:787–90.
Google Scholar
Cedolini C, Bertozzi S, Londero AP, Yanova M, Seriau L, Bernardi S, et al. Clinicopathological characteristics and outcome of high grade breast cancer: our 9 years’ experience. Eur J Gynaecol Oncol. 2017;38:708–14.
Google Scholar
Cedolini C, Bertozzi S, Londero AP, Bernardi S, Seriau L, Concina S, et al. Type of breast cancer diagnosis, screening, and survival. Clin Breast Cancer. 2014;14(4):235–40. https://doi.org/10.1016/j.clbc.2014.02.004.
Article
PubMed
Google Scholar
Davis MB, Liu X, Wang S, Reeves J, Khramtsov A, Huo D, et al. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity. Mol Cancer. 2013;12(1):40. https://doi.org/10.1186/1476-4598-12-40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cook KL, Shajahan AN, Clarke R. Autophagy and endocrine resistance in breast cancer. Expert Rev Anticancer Ther. 2011;11(8):1283–94. https://doi.org/10.1586/era.11.111.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hurvitz SA, Hu Y, O’Brien N, Finn RS. Current approaches and future directions in the treatment of HER2-positive breast cancer. Cancer Treat Rev. 2013;39(3):219–29. https://doi.org/10.1016/j.ctrv.2012.04.008.
Article
CAS
PubMed
Google Scholar
Vicier C, Dieci MV, Arnedos M, Delaloge S, Viens P, Andre F. Clinical development of mTOR inhibitors in breast cancer. Breast Cancer Res. 2014;16(1):203. https://doi.org/10.1186/bcr3618.
Article
PubMed
PubMed Central
Google Scholar
Manna S, Holz MK. Tamoxifen action in ER-negative breast Cancer. Sign Transduct Insights. 2016;5:1–7. https://doi.org/10.4137/STI.S29901.
Article
PubMed
PubMed Central
Google Scholar
Kim YR, Park MS, Eum KH, Kim J, Lee JW, Bae T, et al. Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer. Oncotarget. 2015;6(31):31030–8. https://doi.org/10.18632/oncotarget.5208.
Article
PubMed
PubMed Central
Google Scholar
Napolitano G, Ballabio A. TFEB at a glance. J Cell Sci. 2016;129(13):2475–81. https://doi.org/10.1242/jcs.146365.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, et al. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol. 2014;11(8):465–75. https://doi.org/10.1038/nrurol.2014.162.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martina JA, Diab HI, Li H, Puertollano R. Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis. Cell Mol Life Sci. 2014;71(13):2483–97. https://doi.org/10.1007/s00018-014-1565-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shin HJR, Kim H, Oh S, Lee JG, Kee M, Ko HJ, et al. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature. 2016;534(7608):553–7. https://doi.org/10.1038/nature18014.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lapierre LR, Kumsta C, Sandri M, Ballabio A, Hansen M. Transcriptional and epigenetic regulation of autophagy in aging. Autophagy. 2015;11(6):867–80. https://doi.org/10.1080/15548627.2015.1034410.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brooks CL, Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer. 2009;9(2):123–8. https://doi.org/10.1038/nrc2562.
Article
CAS
PubMed
Google Scholar
Qiu G, Li X, Che X, Wei C, He S, Lu J, et al. SIRT1 is a regulator of autophagy: implications in gastric cancer progression and treatment. FEBS Lett. 2015;589(16):2034–42. https://doi.org/10.1016/j.febslet.2015.05.042.
Article
CAS
PubMed
Google Scholar
Lee H, Kim KR, Noh SJ, Park HS, Kwon KS, Park BH, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. Hum Pathol. 2011;42(2):204–13. https://doi.org/10.1016/j.humpath.2010.05.023.
Article
CAS
PubMed
Google Scholar
Wu M, Wei W, Xiao X, Guo J, Xie X, Li L, et al. Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Med Oncol. 2012;29(5):3240–9. https://doi.org/10.1007/s12032-012-0260-6.
Article
CAS
PubMed
Google Scholar
Mustafa MF, Saliluddin SM, Fakurazi S, Tizen Laim NMS, Md Pauzi SH, Nik Yahya NH, et al. Expression of autophagy and Mitophagy markers in breast Cancer tissues. Front Oncol. 2021;11:612009. https://doi.org/10.3389/fonc.2021.612009.
Article
PubMed
PubMed Central
Google Scholar
Liu J, Yue W, Chen H. The correlation between autophagy and tamoxifen resistance in breast cancer. Int J Clin Exp Pathol. 2019;12(6):2066–74.
CAS
PubMed
PubMed Central
Google Scholar
Schmitt M, Wilhelm OG, Noske A, Schricker G, Napieralski R, Vetter M, et al. Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy. Breast Care (Basel). 2018;13:425–433.
Aubele M, Schmitt M, Napieralski R, Paepke S, Ettl J, Absmaier M, et al. The predictive value of PITX2 DNA methylation for high-risk breast Cancer therapy: current guidelines, medical needs, and challenges. Dis Markers. 2017;2017:4934608–14. https://doi.org/10.1155/2017/4934608.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hartmann O, Spyratos F, Harbeck N, Dietrich D, Fassbender A, Schmitt M, et al. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clin Cancer Res. 2009;15(1):315–23. https://doi.org/10.1158/1078-0432.CCR-08-0166.
Article
CAS
PubMed
Google Scholar
Nimmrich I, Sieuwerts AM, Meijer-van Gelder ME, Schwope I, Bolt-de Vries J, Harbeck N, et al. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. Breast Cancer Res Treat. 2008;111(3):429–37. https://doi.org/10.1007/s10549-007-9800-8.
Article
CAS
PubMed
Google Scholar
Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, et al. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol. 2008;26(31):5036–42. https://doi.org/10.1200/JCO.2007.14.1697.
Article
CAS
PubMed
Google Scholar
Langholz B. Case–Cohort Study. In Encyclopedia of Biostatistics. Chichester: John Wiley & Sons, Ltd; 2005.
Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, et al. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomark Prev. 2010;19(2):492–502. https://doi.org/10.1158/1055-9965.EPI-09-0532.
Article
CAS
Google Scholar
Myckatyn T, Wagner I, Mehrara B, Crosby M, Park J, Qaqish B, et al. Cancer recurrence after fat transfer (CRAFT)- a multicenter case-cohort study. Plast Reconstr Surg. 2017;139(1):11–8. https://doi.org/10.1097/PRS.0000000000002838.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cai J, Zeng D. Sample size/power calculation for case-cohort studies. Biometrics. 2004;60(4):1015–24. https://doi.org/10.1111/j.0006-341X.2004.00257.x.
Article
PubMed
Google Scholar
Arnone P, Zurrida S, Viale G, Dellapasqua S, Montagna E, Arnaboldi P, et al. The TNM classification of breast cancer: need for change. Updat Surg. 2010;62(2):75–81. https://doi.org/10.1007/s13304-010-0014-y.
Article
Google Scholar
Perry N, Puthaar E, European Commission Directorate-General Health & Consumer Protection. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006.
Google Scholar
Cedolini C, Bertozzi S, Londero AP, Seriau L, Andretta M, Agakiza D, et al. Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer. Int J Clin Exp Pathol. 2015;8(10):13304–13.
PubMed
PubMed Central
Google Scholar
Lakhani SR, International Agency for Research on Cancer, World Health Organization. WHO Classification of Tumours of the Breast. In: Number fourth in World Health Organization Classification of Tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2012.
Google Scholar
Compton CC. AJCC Cancer staging atlas a companion to the seventh editions of the AJCC Cancer staging manual and handbook. New York, NY: Springer; 2012.
Google Scholar
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10. https://doi.org/10.1111/j.1365-2559.1991.tb00229.x.
Article
CAS
PubMed
Google Scholar
Tavassoli FA, Eusebi V. Tumors of the Mammary Gland. In: Number fasc. 10 in AFIP Atlas of Tumor Pathology. 4rth Series ed. Washington, D.C: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2009.
Google Scholar
Bernardi S, Bertozzi S, Londero AP, Angione V, Petri R, Giacomuzzi F. Prevalence and risk factors of intraoperative identification failure of sentinel lymph nodes in patients affected by breast cancer. Nucl Med Commun. 2013;34(7):664–73. https://doi.org/10.1097/MNM.0b013e328361cd84.
Article
PubMed
Google Scholar
Cedolini C, Bertozzi S, Seriau L, Londero AP, Concina S, Cattin F, et al. Eight-year experience with the intraoperative frozen section examination of sentinel lymph node biopsy for breast cancer in a north-Italian university center. Int J Clin Exp Pathol. 2014;7(1):364–71.
PubMed
Google Scholar
Calcagno A, Grassi T, Mariuzzi L, Marzinotto S, Londero AP, Orsaria M, et al. Expression patterns of Aurora a and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model. Hum Reprod. 2011;26(10):2731–41. https://doi.org/10.1093/humrep/der264.
Article
CAS
PubMed
Google Scholar
Londero AP, Calcagno A, Grassi T, Marzinotto S, Orsaria M, Beltrami CA, et al. Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues. Virchows Arch. 2012;461(5):589–99. https://doi.org/10.1007/s00428-012-1301-4.
Article
CAS
PubMed
Google Scholar
Londero AP, Bernardi S, Bertozzi S, Angione V, Gentile G, Dri C, et al. Synchronous and metachronous breast malignancies: a cross-sectional retrospective study and review of the literature. Biomed Res Int. 2014;2014:250727–10. https://doi.org/10.1155/2014/250727.
Article
PubMed
PubMed Central
Google Scholar
Grassi T, Calcagno A, Marzinotto S, Londero AP, Orsaria M, Canciani GN, et al. Mismatch repair system in endometriotic tissue and eutopic endometrium of unaffected women. Int J Clin Exp Pathol. 2015;8(2):1867–77.
PubMed
PubMed Central
Google Scholar
Orsaria M, Londero AP, Marzinotto S, Di Loreto C, Marchesoni D, Mariuzzi L. Placental type alkaline phosphatase tissue expression in ovarian serous carcinoma. Cancer Biomark. 2016;17(4):479–86. https://doi.org/10.3233/CBM-160665.
Article
CAS
PubMed
Google Scholar
Londero AP, Orsaria M, Marzinotto S, Grassi T, Fruscalzo A, Calcagno A, et al. Placental aging and oxidation damage in a tissue micro-array model: an immunohistochemistry study. Histochem Cell Biol. 2016;146(2):191–204. https://doi.org/10.1007/s00418-016-1435-6.
Article
CAS
PubMed
Google Scholar
Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A, et al. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients–technical and clinical validation in a multi-Centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Eur J Cancer. 2007;43(11):1679–86. https://doi.org/10.1016/j.ejca.2007.04.025.
Article
CAS
PubMed
Google Scholar
Hernández HG, Tse MY, Pang SC, Arboleda H, Forero DA. Optimizing methodologies for PCR-based DNA methylation analysis. BioTechniques. 2013;55(4):181–97. https://doi.org/10.2144/000114087.
Article
CAS
PubMed
Google Scholar
Perkins J, Napieralski R, Schricker G, Piednoir E, Manner O, Bona A, et al. therascreenPITX2 RGQ PCR assay for the assessment of PITX2 DNA-methylation status to investigate the role of the transcription factor PITX2 and the regulation of the Wnt/ß-catenin pathway in pathophysiological processes. Protoc Exch. 2018:1–38.
Driul L, Bernardi S, Bertozzi S, Schiavon M, Londero AP, Petri R. New surgical trends in breast cancer treatment: conservative interventions and oncoplastic breast surgery. Minerva Ginecol. 2013;65(3):289–96.
CAS
PubMed
Google Scholar
Bertozzi S, Londero AP, Petri R, Bernardi S. Isolated axillary nodal swelling and cancer of unknown primary. Eur J Gynaecol Oncol. 2015;36(2):131–7.
CAS
PubMed
Google Scholar
Bertozzi S, Cedolini C, Londero AP, Baita B, Giacomuzzi F, Capobianco D, et al. Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study. Medicine (Baltimore). 2019;98:e13831.
Article
Google Scholar
Bernardi S, Bertozzi S, Londero AP, Giacomuzzi F, Angione V, Dri C, et al. Nine years of experience with the sentinel lymph node biopsy in a single Italian center: a retrospective analysis of 1,050 cases. World J Surg. 2012;36(4):714–22. https://doi.org/10.1007/s00268-011-1420-0.
Article
PubMed
Google Scholar
Bernardi S, Bertozzi S, Londero AP, Gentile G, Angione V, Petri R. Influence of surgical margins on the outcome of breast cancer patients: a retrospective analysis. World J Surg. 2014;38(9):2279–87. https://doi.org/10.1007/s00268-014-2596-x.
Article
PubMed
Google Scholar
Rifaï K, Judes G, Idrissou M, Daures M, Bignon YJ, Penault-Llorca F, et al. Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer. Oncotarget. 2017;8(67):110922–30. https://doi.org/10.18632/oncotarget.23006.
Article
PubMed
PubMed Central
Google Scholar
Giatromanolaki A, Sivridis E, Kalamida D, Koukourakis MI. Transcription factor EB expression in early breast Cancer relates to lysosomal/Autophagosomal markers and prognosis. Clin Breast Cancer. 2017;17(3):e119–25. https://doi.org/10.1016/j.clbc.2016.11.006.
Article
CAS
PubMed
Google Scholar
Cheng H, Qin Y, Fan H, Su P, Zhang X, Zhang H, et al. Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagn Pathol. 2013;8(1):129. https://doi.org/10.1186/1746-1596-8-129.
Article
CAS
PubMed
PubMed Central
Google Scholar
Habashy HO, Rakha EA, Ellis IO, Powe DG. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer. Breast Cancer Res Treat. 2013;140(2):307–16. https://doi.org/10.1007/s10549-013-2614-y.
Article
CAS
PubMed
Google Scholar
Dong M, Wan X, Yuan ZY, Wei L, Fan XJ, Wang T, et al. Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Med Oncol. 2013;30:355.
Won KY, Kim GY, Kim YW, Song JY, Lim SJ. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum Pathol. 2010;41(1):107–12. https://doi.org/10.1016/j.humpath.2009.07.006.
Article
CAS
PubMed
Google Scholar
Kim S, Jung WH, Koo JS. Differences in autophagy-related activity by molecular subtype in triple-negative breast cancer. Tumour Biol. 2012;33(5):1681–94. https://doi.org/10.1007/s13277-012-0424-1.
Article
CAS
PubMed
Google Scholar
Fujiwara T, Mori Y, Chu DL, Koyama Y, Miyata S, Tanaka H, et al. CARM1 regulates proliferation of PC12 cells by methylating HuD. Mol Cell Biol. 2006;26(6):2273–85. https://doi.org/10.1128/MCB.26.6.2273-2285.2006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Calvanese V, Lara E, Suárez-Alvarez B, Abu Dawud R, Vázquez-Chantada M, Martínez-Chantar ML, et al. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A. 2010;107(31):13736–41. https://doi.org/10.1073/pnas.1001399107.
Article
PubMed
PubMed Central
Google Scholar
Paylakhi SH, Fan JB, Mehrabian M, Sadeghizadeh M, Yazdani S, Katanforoush A, et al. Effect of PITX2 knockdown on transcriptome of primary human trabecular meshwork cell cultures. Mol Vis. 2011;17:1209–21.
CAS
PubMed
PubMed Central
Google Scholar
Zou CF, Jia L, Jin H, Yao M, Zhao N, Huan J, et al. Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer. 2011;11(1):22. https://doi.org/10.1186/1471-2407-11-22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Absmaier M, Napieralski R, Schuster T, Aubele M, Walch A, Magdolen V, et al. PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients. Int J Oncol. 2018;52(3):755–67. https://doi.org/10.3892/ijo.2018.4241.
Article
CAS
PubMed
PubMed Central
Google Scholar